Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Test-retest Study to Assess Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of AH111585 (18F) Injection.

NCT00918281 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT00918281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00918281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Test-retest Study to Assess Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of AH111585 (18F) Injection.
Lead sponsor
GE Healthcare
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
October 31, 2011
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, head and neck cancer, high grade gliomas, lung cancer, renal cell carcinoma, sarcoma, solid tumors